Antibodies Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

Published on : Aug-2017 | List of Tables : 271 | List of Figures : 99 | No. of Pages : 170 | Report Code : FACT194MR |

The global demand for antibodies is expected to remain moderate in the forthcoming years. Increasing prevalence of chronic ailments such as autoimmune diseases, cancer, diabetes and others is encouraging manufacturers to step up investments in R&D activities pertaining to antibodies. In addition, frequent outbreak of infectious diseases in various parts of the world coupled with growing popularity of protein therapeutics, is driving the sales of antibodies drugs. Sales of antibody-based medicines is expected to remain steady in developed regions such as Europe and North America. At the same time, introduction of alternative therapeutic drugs is projected to impact the growth of the global antibodies market. Moreover, factors such as risk of side effects related with antibodies and high-cost remain the major growth deterrents of the market. According to the latest report published by Fact.MR, the global antibodies market is expected to surpass a valuation of US$ 3,000 Mn by end of 2022, reflecting a steady CAGR between 2017 and 2022.

Antibodies (Ab) are also known as immunoglobulin (Ig). These are the large, Y-shaped protein that are produced primarily by plasma cells present in the blood in response to pathogens such as viruses and bacteria. Antibodies are capable of identifying unique molecules with harmful agents. Antibodies are used in various therapeutic areas as well as in diagnostics of disease indications such as rheumatoid arthritis, non-Hodgkin lymphoma, psoriasis, macular degeneration, asthma, Crohn’s disease, and hypercholesterolemia.

Market Taxonomy

Product Type

End User

Application

Immune Checkpoint Antibodies

Biopharmaceutical Companies

Drug Discovery & Development

Epitope Tag Antibodies

Contract Research Organizations (CROs)

Basic Research

Isotype Control Antibodies

Academic & Research Institutes

Toxicity Screening

Primary Antibodies

Forensic Science Laboratories

Biopharmaceutical Production

Assay Antibodies (includes secondary antibodies)

Food & Beverage Companies

Drug Screening

Other

Diagnostic Centers

Tissue Engineering

 

Others

Forensic Testing

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

North America at the Forefront of the Global Antibodies Market

Currently, North America dominates the global antibodies market in terms of revenue and trend is projected continue in 2017 and beyond. In addition, the market in the region is expected to increase at a moderate CAGR during the forecast period (2017-2022). Presence of leading market players and existence of a well-established healthcare infrastructure is supporting the growth of the market in the region.

Primary Antibodies to Remain Top Selling Product Type  

On the basis of product type, the primary antibodies segment currently accounts for the highest share of the global antibodies market in terms of revenue. Towards the end of forecast period, the segment is expected to reach a valuation in excess of US$ 1,091 Mn, reflecting a steady CAGR. The primary antibodies segment is projected to create an absolute $ opportunity of US$ 168.4 Mn between 2017 and 2022.

Competition Tracking

The report has also profiled key players operating in the global antibodies market, which include Abcam Plc, A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Genscript Biotech Corporation, Sigma Aldrich Corp, Crown Bioscience, Inc., Thermo Fisher Scientific, Inc.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Medical research institutes as well as leading companies in the pharmaceutical industry are stepping up their efforts toward development of profound therapeutics, which is resulting is development of efficacious antibody-based drugs. This Fact.MR report analyzes the expansion of global antibodies market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

Scope

The scope of Fact.MR’s report is to analyze the global antibodies market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Drug manufacturers, research institutes, and raw material suppliers in the global antibodies market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to antibodies.        

Summary

The report commences with a brief information of the global antibodies market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global antibodies market.     

Overview

The next section offers an overview of the global antibodies market. This comprises an introduction to the market, along with a standard definition of the product – antibodies. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.      

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global antibodies market, the report provides updates about market opportunities, which can benefit leading manufacturers of antibody-based drugs and medicines. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for antibody-based drug manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.  

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global antibodies market. Product type, end user, application and region are key segments that define the growth of the global antibodies market. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.     

The report’s last section comprises of the global antibodies market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global antibodies market.     

Research Methodology

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,

  • Primary research
  • Secondary research
  • Trade research
  • Focused interviews
  • Social media analysis

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Our Clients

Antibodies Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022